19 research outputs found

    ELemental abundances of Planets and brown dwarfs Imaged around Stars (ELPIS): I. Potential Metal Enrichment of the Exoplanet AF Lep b and a Novel Retrieval Approach for Cloudy Self-luminous Atmospheres

    Full text link
    AF Lep A+b is a remarkable planetary system hosting a gas-giant planet that has the lowest dynamical mass among directly imaged exoplanets. We present an in-depth analysis of the atmospheric composition of the star and planet to probe the planet's formation pathway. Based on new high-resolution spectroscopy of AF Lep A, we measure a uniform set of stellar parameters and elemental abundances (e.g., [Fe/H] = 0.27±0.31-0.27 \pm 0.31 dex). The planet's dynamical mass (2.80.5+0.62.8^{+0.6}_{-0.5} MJup_{\rm Jup}) and orbit are also refined using published radial velocities, relative astrometry, and absolute astrometry. We use petitRADTRANS to perform chemically-consistent atmospheric retrievals for AF Lep b. The radiative-convective equilibrium temperature profiles are incorporated as parameterized priors on the planet's thermal structure, leading to a robust characterization for cloudy self-luminous atmospheres. This novel approach is enabled by constraining the temperature-pressure profiles via the temperature gradient (dlnT/dlnP)(d\ln{T}/d\ln{P}), a departure from previous studies that solely modeled the temperature. Through multiple retrievals performed on different portions of the 0.94.20.9-4.2 μ\mum spectrophotometry, along with different priors on the planet's mass and radius, we infer that AF Lep b likely possesses a metal-enriched atmosphere ([Fe/H] >1.0> 1.0 dex). AF Lep b's potential metal enrichment may be due to planetesimal accretion, giant impacts, and/or core erosion. The first process coincides with the debris disk in the system, which could be dynamically excited by AF Lep b and lead to planetesimal bombardment. Our analysis also determines Teff800T_{\rm eff} \approx 800 K, log(g)3.7\log{(g)} \approx 3.7 dex, and the presence of silicate clouds and dis-equilibrium chemistry in the atmosphere. Straddling the L/T transition, AF Lep b is thus far the coldest exoplanet with suggested evidence of silicate clouds.Comment: AJ, in press. Main text: Pages 1-32, Figures 1-15, Tables 1-6. All figures and tables after References belong to the Appendix (Pages 32-58, Figures 16-20, Table 7). For supplementary materials, please refer to the Zenodo repository https://doi.org/10.5281/zenodo.826746

    Local therapy of cancer with free IL-2

    Get PDF
    This is a position paper about the therapeutic effects of locally applied free IL-2 in the treatment of cancer. Local therapy: IL-2 therapy of cancer was originally introduced as a systemic therapy. This therapy led to about 20% objective responses. Systemic therapy however was very toxic due to the vascular leakage syndrome. Nevertheless, this treatment was a break-through in cancer immunotherapy and stimulated some interesting questions: Supposing that the mechanism of IL-2 treatment is both proliferation and tumoricidal activity of the tumor infiltrating cells, then locally applied IL-2 should result in a much higher local IL-2 concentration than systemic IL-2 application. Consequently a greater beneficial effect could be expected after local IL-2 application (peritumoral = juxtatumoral, intratumoral, intra-arterial, intracavitary, or intratracheal = inhalation). Free IL-2: Many groups have tried to prepare a more effective IL-2 formulation than free IL-2. Examples are slow release systems, insertion of the IL-2 gene into a tumor cell causing prolonged IL-2 release. However, logistically free IL-2 is much easier to apply; hence we concentrated in this review and in most of our experiments on the use of free IL-2. Local therapy with free IL-2 may be effective against transplanted tumors in experimental animals, and against various spontaneous carcinomas, sarcomas, and melanoma in veterinary and human cancer patients. It may induce rejection of very large, metastasized tumor loads, for instance advanced clinical tumors. The effects of even a single IL-2 application may be impressive. Not each tumor or tumor type is sensitive to local IL-2 application. For instance transplanted EL4 lymphoma or TLX9 lymphoma were not sensitive in our hands. Also the extent of sensitivity differs: In Bovine Ocular Squamous Cell Carcinoma (BOSCC) often a complete regression is obtained, whereas with the Bovine Vulval Papilloma and Carcinoma Complex (BVPCC) mainly stable disease is attained. Analysis of the results of local IL-2 therapy in 288 cases of cancer in human patients shows that there were 27% Complete Regressions (CR), 23% Partial Regressions (PR), 18% Stable Disease (SD), and 32% Progressive Disease (PD). In all tumors analyzed, local IL-2 therapy was more effective than systemic IL-2 treatment. Intratumoral IL-2 applications are more effective than peritumoral application or application at a distant site. Tumor regression induced by intratumoral IL-2 application may be a fast process (requiring about a week) in the case of a highly vascular tumor since IL-2 induces vascular leakage/edema and consequently massive tumor necrosis. The latter then stimulates an immune response. In less vascular tumors or less vascular tumor sites, regression may require 9–20 months; this regression is mainly caused by a cytotoxic leukocyte reaction. Hence the disadvantageous vascular leakage syndrome complicating systemic treatment is however advantageous in local treatment, since local edema may initiate tumor necrosis. Thus the therapeutic effect of local IL-2 treatment is not primarily based on tumor immunity, but tumor immunity seems to be useful as a secondary component of the IL-2 induced local processes. If local IL-2 is combined with surgery, radiotherapy or local chemotherapy the therapeutic effect is usually greater than with either therapy alone. Hence local free IL-2 application can be recommended as an addition to standard treatment protocols. Local treatment with free IL-2 is straightforward and can readily be applied even during surgical interventions. Local IL-2 treatment is usually without serious side effects and besides minor complaints it is generally well supported. Only small quantities of IL-2 are required. Hence the therapy is relatively cheap. A single IL-2 application of 4.5 million U IL-2 costs about 70 Euros. Thus combined local treatment may offer an alternative in those circumstances when more expensive forms of treatment are not available, for instance in resource poor countries

    Crop pests and predators exhibit inconsistent responses to surrounding landscape composition

    Get PDF
    The idea that noncrop habitat enhances pest control and represents a win–win opportunity to conserve biodiversity and bolster yields has emerged as an agroecological paradigm. However, while noncrop habitat in landscapes surrounding farms sometimes benefits pest predators, natural enemy responses remain heterogeneous across studies and effects on pests are inconclusive. The observed heterogeneity in species responses to noncrop habitat may be biological in origin or could result from variation in how habitat and biocontrol are measured. Here, we use a pest-control database encompassing 132 studies and 6,759 sites worldwide to model natural enemy and pest abundances, predation rates, and crop damage as a function of landscape composition. Our results showed that although landscape composition explained significant variation within studies, pest and enemy abundances, predation rates, crop damage, and yields each exhibited different responses across studies, sometimes increasing and sometimes decreasing in landscapes with more noncrop habitat but overall showing no consistent trend. Thus, models that used landscape-composition variables to predict pest-control dynamics demonstrated little potential to explain variation across studies, though prediction did improve when comparing studies with similar crop and landscape features. Overall, our work shows that surrounding noncrop habitat does not consistently improve pest management, meaning habitat conservation may bolster production in some systems and depress yields in others. Future efforts to develop tools that inform farmers when habitat conservation truly represents a win–win would benefit from increased understanding of how landscape effects are modulated by local farm management and the biology of pests and their enemies

    Finishing the euchromatic sequence of the human genome

    Get PDF
    The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
    corecore